The hypothesis that endogenous PGE2 mediates defective thick ascending limb (TAL) Cl reabsorption (percent delivered load: FRY0%) in rats with vitamin D-induced chronic hypercalcemia (HC) was tested by measuring FRG% in loop segments microperfused in vivo in HC and control rats treated acutely with indomethacin (Indo) or its vehicle, and obtaining the corresponding outer medullary IPGE2J. Microperfusion conditions were developed in which FR0% was exclusively furosemide sensitive. To determine the cellular mechanism, tubules were perfused acutely with forskolin (FSK), cAMP, or the protein kinase C inhibitor staurosporine (SSP). Outer medullary [PGE21 in HC rats was 9 to 10 times greater than control and could be normalized by Indo. FR0% was 20% lower in HC rats infused with vehicle, and Indo, FSK, and cAMP returned FRa% to normal despite sustained HC. Indo or FSK had no effect on FR0% in control rats and Indo did not prevent inhibition of FR0% by luminal PGE2 (1 gM). Luminal SSP (lo-7, 10-8 M) in HC did not return FR0% to control values. We conclude that impaired TAL FR0,% in HC occurs at a precAMP site and is due to endogenous PGE2 and not to HC. (J.
Introduction
There is ample evidence from in vitro studies that PGE2 can antagonize arginine vasopressin (AVP)' stimulation of thick ascending limb (TAL) NaCl reabsorption (1) (2) (3) (4) . More recently, PGE2 has been shown to specifically inhibit transportrelated ouabain-sensitive oxygen consumption in rabbit TAL cells (5) , and decrease the NaK-ATPase activity of isolated medullary TAL (mTAL) in the rat (6) . The mTAL should be exposed to PGE2 synthesized by outer medullary interstitial cells and collecting ducts (3) . In addition, TAL cells have been shown to have a limited capacity to synthesize PGE2 (3, 5) . One earlier free-flow micropuncture study indicated an effect of endogenous prostaglandins on loop of Henle Cl reabsorption in volume-expanded (10% body weight) animals (7) . Interpretation of the results of these experiments, which rely exclusively on the use of cyclooxygenase inhibition, is complicated since arachidonic acid can be metabolized by the outer medulla via the cytochrome P-450 pathway (8, 9) and perhaps the lipoxygenase pathway ( 10) . Metabolites ofthe P-450 pathway have been shown to inhibit ion transport in the TAL in vitro (11 ) . Indomethacin (Indo) at high concentrations ( 10-4 M) has been shown to inhibit all three metabolic pathways ( 12) . Due to the presence of the countercurrent system in the renal medulla, estimation ofdrug concentrations in vivo can be problematic. Therefore, despite significant research efforts in the area of PGE2-AVP interactions, there is no evidence that chronic activation of renal PGE2 production can cause inhibition of TAL transport, and there are no pathophysiological conditions in which inhibition of TAL NaCl reabsorption can be attributed to altered renal PGE2 metabolism (3, 4, 13) .
Chronic hypercalcemia (HC) in man and animals is associated with disturbances in water intake, renal concentrating ability, and loop of Henle function (14) (15) (16) . Recently, in functionally isolated perfused loops of Henle using a microstopflow technique, chronic hypercalcemia in rats was shown to be associated with inhibition of TAL NaCl reabsorption ( 14) . What is the mechanism ofimpaired TAL NaCl reabsorption in chronic hypercalcemia? There is evidence from in vitro studies that acute increases in extracellular [Ca2+] can directly inhibit AVP stimulated production of cAMP and thus could mediate the transport defect ( 17 ) . In acute hypercalcemia, loop Cl reabsorption is decreased by an indomethacin-resistant mechanism ( 18) . However, two previous studies have shown that renal PGE2 excretion is strikingly elevated in rats with chronic hypercalcemia ( 15, 19) . Evidence was provided from one ofthese studies that elevated PGs may underlie the AVP-resistant concentrating defect ( 19), however, the results of the other study did not support this hypothesis ( 15 ) . It is possible that elevated PGE2 and not the hypercalcemic state impairs TAL transport. Although renal excretion of PGE2 is increased in rats with chronic hypercalcemia, the source of the PGE2 is unknown. For example, given the capacity of inner medulla to synthesize PGE2 (3) , it is possible that PGE2 is not elevated in the outer medulla and may not have a major impact on TAL function.
Therefore, the present study tested the hypothesis that endogenous PGE2 mediates impaired TAL NaCl reabsorption in functionally isolated perfused nephrons in vivo in chronic hypercalcemia. Microperfusion conditions were developed in which Cl reabsorption was exclusively furosemide sensitive. TAL Cl reabsorption was measured in loop segments micro-perfused in rats with chronic HC and pair-fed control rats treated with Indo or its vehicle. In hypercalcemic and control rats prepared under similar conditions, PGE2 was extracted from the outer medulla and measured by RIA. Hypotheses regarding the underlying cellular mechanism by which TAL Cl reabsorption is inhibited in chronic HC were tested using luminal addition of forskolin (FSK), cAMP, and the protein kinase C inhibitor staurosporine (SSP). Further microperfusion experiments were performed to determine if Indo impairs the ability of PGE2 to inhibit TAL transport in normal rats.
Methods
Studies were carried out using 109 male Sprague-Dawley rats weighing 280-350 g. Chronic HC was induced by feeding a normal electrolyte diet containing 4.25 mg/kg diet of dihydrotachysterol (DHT), a vitamin D analogue, for 4-6 d ( 14) . Control measurements were made in rats pair fed (7 g/ 100 g body wt per d) the identical normal diet without DHT ( 14) . All rats were given tap water to drink. In the microperfusion experiments to examine the effects of luminal furosemide or PGE2, animals were fed standard rat chow.
Microperfusion studies. Rats were anesthetized with Inactin 100 mg/kg body wt, i.p. and prepared for microperfusion studies as previously described ( 14) ; a brief summary follows. Right and left jugular veins were cannulated to allow infusion ofsolutions, anesthetic maintenance, and lissamine green. The left carotid artery was cannulated to monitor blood pressure and to allow for blood collections. A tracheostomy was performed. The left kidney was exposed, placed in a lucite cup, and warmed agar was placed around the kidney to form a well. The kidney was bathed in water-equilibrated paraffin oil. The ureter was cannulated for urine collections. Rats were infused intravenously at 1% body wt/h with 0.9% NaCl containing either Indo (5 mg/kg per h) or 0.14% Na2CO3 as a vehicle, after receiving a loading dose ofeither 5 mg/kg Indo or the corresponding amount of vehicle. Rats were infused with 0.9% NaCl without Indo or vehicle in microperfusion studies with furosemide, FSK, cAMP and SSP. Each rat was infused intravenously with Plasmanate (5% human plasma protein) in buffered saline at the rate of 1 ml/ h except in the microperfusion studies with luminal furosemide. To ensure similar circulating levels of AVP, the animals were given a loading dose of45 pg ofthe V2 agonist, 1-[ desamino ] -8-Darginine vasopressin (dDAVP), and the analogue was added to the Plasmanate infusion to deliver 45 pg/min (20) . An Figure 1 . Effect of 1 mM furosemide addition to the luminal perfusate to abolish net Cl reabsorption in the functionally isolated perfused loop segment in control rats in vivo. Cl reabsorption is expressed as a percent of delivered Cl. Number of tubules per group is given in Table I . P value calculated using Student's t test for unpaired data.
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Results

Assessment offurosemide-sensitive Cl reabsorption
Data collected during these microperfusion experiments obtained in normal rats are summarized in Table I and Fig. 1 . In all the microperfusion studies, the microperfusion pump was set to deliver 22 nl/min. The actual perfusion rate calculated from the [ 14C]inulin delivery is quite close to this value (Table  I) . It is also clear that the standard loop perfusate used in our studies virtually abolished fluid reabsorption by the loop segment. This fact is evident by comparing the volume perfused and the volume collected per min as well as the C/P [Inulin] ratio. To assess the contribution ofthe TAL to net C1 reabsorption under these experimental conditions, the fraction of loop Cl reabsorption that could be inhibited by the addition offurosemide (1 mM) to the luminal perfusate was determined. As documented in Table I calculated from the data presented in Table II was significant at the level P < 0.00001, the correlation coefficient was -0.894 and the R2 value was 79.9%.
To reduce the variation due to differences in Cl delivery and in the length of the perfused loop segments, loop Cl reabsorption is expressed as a fraction of the amount delivered to the segment, i.e., FRa%, in Fig. 1 . Normal loops of Henle reabsorb 60±3.6% of the delivered Cl, which is reversed to a small degree of secretion -8.6±2.2 by the addition of 1 mM furosemide to the luminal perfusate.
Mechanism underlying impaired TAL Cl reabsorption in HC: effects ofIndo, forskolin, cAMP, staurosporine, and PGE2
After 5 d ofconsuming the DHT-containing diet, blood [Ca2+] was on average 1.57±0.06 mM (SD) versus 1.29±0.06 mM (SD) in pair-fed control rats. The exclusion criteria used in the study prevented the values from overlapping. Table II , Cl reabsorption in HC rats after exposure to FSK increased to values similar to those measured in control rats. Fig. 2 illustrates the increase in FR a% in HC rats treated with FSK in the luminal perfusate and lack ofa significant effect of FSK to stimulate Cl reabsorption in control rats.
The above results indicate that sustained HC does not impair the mechanism by which cAMP produces its effect on TAL transport. Logically, provision of cAMP should have the same effect as treatment with FSK, however, by itself would not indicate at which step PGE2 impairs TAL function. The hypothesis that PGE2 impairs TAL transport at a pre-cAMP step was tested in HC rats in which cAMP was provided by perfusing the loop segment with 8-p-CPT-cAMP for 30 min. Preliminary results showed variable stimulation when loops were perfused for only 20 min. In these experiments, the perfu- (Table II) . The effect of cAMP to increase FRY% is illustrated in Fig. 2 
Discussion
The results of the present microperfusion study of the integrated response of the TAL in vivo demonstrate that acute PG synthesis inhibition in HC animals, but not in controls, is associated with stimulation of TAL Cl reabsorption and a normalization oftransport despite sustained HC. In animals treated in a similar manner we demonstrate that endogenous PGE2 in the outer medulla of HC rats is elevated 9 to 10 times compared with control rats and can be reduced to normal after acute treatment with Indo. This is the first report ofa pathophysiological condition in which inhibition of TAL Cl reabsorption can be attributed to increased renal PGE2 production. The issues to be addressed include (a) the specificity of the method used to assess TAL Cl reabsorption, (b) endogenous PGE2 impairment of TAL Cl reabsorption in HC in vivo, (c) the hypotheses regarding the signal transduction pathway by which PGE2 impairs Cl reabsorption, and (d) the effect of elevated extracellular fluid (ECF) [Ca2+] on TAL Cl reabsorption. Assessment of TAL Cl reabsorption in vivo Microperfusion conditions. We have used the technique ofcontinuous microperfusion of the loop of Henle in functionally isolated cortical nephrons in vivo. Under these conditions, glomerular filtrate is diverted and control ofluminal fluid composition and delivery is permitted. In addition, the segment of interest remains within the renal interstitium. The segment consists of a portion of the proximal convoluted tubule, the pars recta, thin descending limb, TAL (medullary and cortical portions, which may be as long as 3 mm [27 ] ), and a portion of the distal convoluted tubule. Each of these regions has distinct fluid and electrolyte permeabilities and transport characteristics. In contrast to other microperfusion studies, we have manipulated the perfusate composition to minimize Cl reabsorption in nephron segments proximal to the TAL. This was achieved by limiting perfusate [Na] to 1 10 mM and [Cl] to 100 mM ([NaHCO3] was 10 mM). In the rat, no net reabsorption or secretion of NaCl and water occur at a luminal [ NaCI ] of 95 mM (21 ). To further prevent fluid reabsorption, mannitol was added. In other respects, the perfusate composition resembles late proximal fluid and the perfusion rate used is only slightly higher than flow rates measured at late proximal sites.
Success in preventing fluid reabsorption (J,) is evident by comparing collected rates with perfused rates, which differed by < 0.2-3 nl/min at the perfusion rate of22 nl/min. This is in clear contrast to other loop segment studies where J. was 2 50% of the perfused rate (18, 28 ( 14, 20) . Specificity offurosemide. Using our modified tubule perfusate and exclusion criteria, the total amount of Cl reabsorbed between the perfusion and collection pipettes could be abolished by I mM furosemide in the perfusate. Can effects of furosemide on other transport systems in the TAL or other nephron segments in the perfused region account for this finding? Because in the present study, Cl was measured and not Na, a reduction in NaHCO3 reabsorption due to inhibition of carbonic anhydrase activity would not have caused an overestimate of the contribution of the TAL. Other studies showing that furosemide can inhibit fluid reabsorption in proximal nephron segments (29) were performed using a luminal
[NaCI] of 155 mM, nearly 60 mM higher than the limiting gradient that can be established by this segment (21). The perfusate [Cl ] in the present study was chosen to approximate the limiting gradient and, in so doing, prevent net NaCl and water reabsorption by the proximal tubule. Although it is possible that furosemide may affect thin descending limb function (30) , this segment is short (extends the length of the inner stripe ofthe outer medulla) and its contribution to net Cl reabsorption is quite small in comparison to that ofthe TAL. Therefore, Cl reabsorption reported in the present study largely reflects net uptake in medullary and cortical TAL in vivo.
TAL inhibition is mediated by endogenous PGE2 in chronic HC
Measurement of outer medullary [PGE2] . The results of the present study show for the first time, rapid reversal ofimpaired TAL Cl reabsorption using a PG synthesis inhibitor. Acute treatment with Indo in the rat has been shown to decrease renal PGE2 excretion by 95% (7). However, given the capacity ofthe inner medulla to synthesize PGE2 (3, 24) , it is possible that urinary PGE2 excretion largely reflects inner medullary production and the medullary TAL may not be exposed to inhibitory concentrations. Therefore, it was essential to establish the presence of elevated PGE2 in the outer medulla of HC rats. In the present study, we show that [PE2] in the outer medulla ofHC rats is 9 to 10 times greater than that measured in controls. Furthermore, acute treatment with Indo, similar to that used in the microperfusion studies, reduced PGE2 in the HC rats to control concentrations. As noted previously, the statistical analysis indicates that HC stimulates outer medullary PGE2 and (3, 24) . However, since the TAL (3, 5, 8) and thin descending limb (33) have a limited capacity to synthesize PGE2, the source of PGE2 produced in HC that inhibits TAL Cl reabsorption can not be deduced.
The concentrations ofPGE2 in the outer medulla measured in the present study are in marked contrast to an earlier study by Stahl et al. (24) in rabbits in which PGE2 extracted from the outer medulla was more than 1,000 times greater. It should be appreciated that in addition to performing the measurements in tissue derived from rabbits, a different method was used to extract and measure PGE2. Since Indo pretreatment was not used, it is not possible to estimate the contribution ofbiosynthesis after excision ofthe tissue and exposure to Indo-in the isolation medium.
Lack of interaction between Indo and PGE2 on TAL Cl reabsorption in vivo. As a further test of the hypothesis that PGE2 mediates the defect in TAL Cl reabsorption, loops of Henle in normal animals were perfused with 1 AM PGE2.
There was an 18% reduction in FR0 % and an increase in the [Cl] (38) that cAMP production in response to AVP by mTAL derived from HC rats is decreased. Phosphotidylinositol system. PGE2 has been shown to exert effects on the cortical collecting duct of the rabbit via three signal transduction pathways; two which are coupled to adenylate cyclase via G, and Gi, and the third coupled to the phosphotidylinositol system through Gp, which leads to protein kinase C (PKC) activation (34, 35, 39) . To test the hypothesis that PGE2 inhibition of Cl reabsorption in the TAL may be due to PKC activation, SSP was used to inhibit PKC activity. Since SSP is not a selective PKC inhibitor (40, 41), we tested the effect of luminally applied l0-7 and 10 8 M SSP on Cl reabsorption in vivo. As shown in Fig. 2 , there was no detectable improvement in TAL Cl reabsorption in HC animals. Bioactivity of SSP was confirmed using a different preparation in an adjacent laboratory (26) . The possibility remains that failure of SSP to affect TAL transport may be due to the fact that the PKC inhibitor was added on the luminal side. However, if PGE2 inhibits TAL transport by a PKC-dependent post-cAMP mechanism or a mechanism independent of cAMP, then increased production of cAMP by FSK or provision of cAMP would not restore Cl reabsorption to normal values. Therefore, it is unlikely that endogenous PGE2 inhibits TAL Cl reabsorption via a PKC-dependent pathway.
Elevated ECF [Ca2 I and TAL Cl reabsorption Previous in vitro studies have shown that an elevation of [Ca2"] to 2 mM in the incubation medium decreases AVPstimulated cAMP production in mouse mTAL ( 17 ) . Since glucagon-and forskolin-stimulated cAMP production were also diminished, the authors proposed that the catalytic subunit of adenylate cyclase was directly inhibited by the increase in external [Ca2 ] . The authors mention that preincubation of the mTAL segments with Indo did not prevent the inhibitory action of the acute increase in [Ca2"]. In the present study, despite the presence of a sustained increase in ECF [Ca2] to > 1.5 but < 2.0 mM, Indo, FSK, and exogenous cAMP were able to reverse inhibition of TAL Cl reabsorption in chronic hypercalcemic rats. This indicates that the increments in ECF [Ca2+] commonly observed in HC do not directly impair Cl reabsorption and do not appear to impair the catalytic subunit of adenylate cyclase in the TAL in vivo. It is not unreasonable to propose that the acute and chronic effects of increased ECF [Ca2+] may differ. However, our results suggest that any direct action of increased ECF [Ca2+] to impair TAL transport by decreasing cAMP production is not sustained in animals with chronic HC.
In summary, our study of the integrated response of the TAL in vivo establishes the link between altered renal PGE2 production and inhibition of TAL Cl reabsorption. Data derived from these studies indicate that outer medullary [PGE2] in normal rats is -2 x 10-1 M and that inhibition of TAL Cl reabsorption is present when [PGE2] increases to approximately 17 x 10-9 M. Acquisition of this information now permits reevaluation of in vitro data regarding physiological versus pharmacological effects of PGE2 on medullary nephron segment function. Our results are consistent with previous suggestions that endogenous PGE2 has little effect on the function of the TAL under normal conditions. We conclude that increased endogenous PGE2, and not HC per se, mediates inhibition of TAL Cl reabsorption at a step proximal to the generation of cAMP and probably does not involve activation of protein kinase C. These findings are consistent with the results of in vitro studies regarding the mechanism of action of PGE2 in the mTAL ( 1, 2). However, current thinking regarding the mechanism by which HC impairs TAL function will have to be reevaluated (4) . In addition, it is possible that the sustained 20% decrease in TAL Cl reabsorption mediated by PGE2 contributes to the urinary concentrating defect associated with HC (14) . Lastly, the mechanism by which PGE2 via decreased cAMP causes inhibition of TAL Cl reabsorption may involve decreased Na/K-ATPase activity (6) or events at the luminal membrane involving the Cl uptake step (42, 43) .
